Cube Labs S.P.A. (IT:CUBE) has released an update.
Cube Labs, an Italian venture builder in the healthcare technology sector, has secured significant funding for its startups Adamas Biotech and DTech. Adamas Biotech received €425,700 to develop a nutraceutical for intestinal health, while DTech obtained €393,700 for a protective biospray and digital platform. These contributions, backed by the National Biodiversity Future Center, will advance Cube Labs’ innovative healthcare projects.
For further insights into IT:CUBE stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- UFC Might Be Netflix’s (NASDAQ:NFLX) Next Big Draw
- Under Armour (NYSE:UAA) Stock Rises Over 30% as Turnaround Plan Works
- All Eyes on Rivian Stock Ahead of Earnings Today — Here’s What Wall Street Expects
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
